Literature DB >> 25813671

Lysosome-controlled efficient ROS overproduction against cancer cells with a high pH-responsive catalytic nanosystem.

Jingke Fu1, Yiran Shao, Liyao Wang, Yingchun Zhu.   

Abstract

Excess reactive oxygen species (ROS) have been proved to damage cancer cells efficiently. ROS overproduction is thus greatly desirable for cancer therapy. To date, ROS production is generally uncontrollable and outside cells, which always bring severe side-effects in the vasculature. Since most ROS share a very short half-life and primarily react close to their site of formation, it would be more efficient if excess ROS are controllably produced inside cancer cells. Herein, we report an efficient lysosome-controlled ROS overproduction via a pH-responsive catalytic nanosystem (FeOx-MSNs), which catalyze the decomposition of H2O2 to produce considerable ROS selectively inside the acidic lysosomes (pH 5.0) of cancer cells. After a further incorporation of ROS-sensitive TMB into the nanosystem (FeOx-MSNs-TMB), both a distinct cell labeling and an efficient death of breast carcinoma cells are obtained. This lysosome-controlled efficient ROS overproduction suggests promising applications in cancer treatments.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25813671     DOI: 10.1039/c5nr00706b

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  9 in total

1.  Enhancing of Nanocatalyst-Driven Chemodynaminc Therapy for Endometrial Cancer Cells Through Inhibition of PINK1/Parkin-Mediated Mitophagy.

Authors:  Xiaodi Gong; Xin Pu; Jing Wang; Linlin Yang; Yunxia Cui; Lijuan Li; Xiao Sun; Jichang Liu; Jingfeng Bai; Yudong Wang
Journal:  Int J Nanomedicine       Date:  2021-09-29

Review 2.  Ferrite Nanoparticles-Based Reactive Oxygen Species-Mediated Cancer Therapy.

Authors:  Shancheng Yu; Huan Zhang; Shiya Zhang; Mingli Zhong; Haiming Fan
Journal:  Front Chem       Date:  2021-04-27       Impact factor: 5.221

3.  Luminescent mesoporous nanorods as photocatalytic enzyme-like peroxidase surrogates.

Authors:  M Carmen Ortega-Liebana; Jose L Hueso; Rodrigo Fernandez-Pacheco; Silvia Irusta; Jesus Santamaria
Journal:  Chem Sci       Date:  2018-08-24       Impact factor: 9.825

4.  Biodegradable 2D Fe-Al Hydroxide for Nanocatalytic Tumor-Dynamic Therapy with Tumor Specificity.

Authors:  Zhenbang Cao; Liang Zhang; Kang Liang; Soshan Cheong; Cyrille Boyer; J Justin Gooding; Yu Chen; Zi Gu
Journal:  Adv Sci (Weinh)       Date:  2018-10-09       Impact factor: 16.806

Review 5.  Fenton/Fenton-like metal-based nanomaterials combine with oxidase for synergistic tumor therapy.

Authors:  Wei Cao; Mengyao Jin; Kang Yang; Bo Chen; Maoming Xiong; Xiang Li; Guodong Cao
Journal:  J Nanobiotechnology       Date:  2021-10-16       Impact factor: 10.435

6.  Targeted therapy for the treatment of gliomas with multifunctional orange emissive carbon dots.

Authors:  Shuyao Liu; Zhuoling Zhong; Chuanwei Zhang; Yanqu Zhou; Chunmei Fu; Xiaoping Xu
Journal:  Nanoscale Adv       Date:  2021-12-17

7.  Colorimetric assay based on NiCo2S4@N,S-rGO nanozyme for sensitive detection of H2O2 and glucose in serum and urine samples.

Authors:  Hanzhang Ye; Yongli Ding; Tingting Liu; Jiani Li; Qi Wang; Yuhao Li; Jingjing Gu; Zhanen Zhang; Xuedong Wang
Journal:  RSC Adv       Date:  2022-07-19       Impact factor: 4.036

8.  Efficient Active Oxygen Free Radical Generated in Tumor Cell by Loading-(HCONH₂)·H₂O₂ Delivery Nanosystem with Soft-X-ray Radiotherapy.

Authors:  Lei Xu; Yiran Shao; Chengkang Chang; Yingchun Zhu
Journal:  Materials (Basel)       Date:  2018-04-12       Impact factor: 3.623

9.  Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.

Authors:  Di Wu; Zi-Qiang Zhu; Hai-Xiao Tang; Zhi-En Shi; Jian Kang; Qiang Liu; Jun Qi
Journal:  Theranostics       Date:  2020-08-02       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.